PharmaBoardroom

Concrete Steps Toward National Pharmacare in Canada

Writing in the September edition of DIA's Global Forum magazine, Dr Judith Glennie examines the specific steps that have been taken in the journey…

Nicolas Dumoulin – General Manager & Head of Human…

Boehringer Ingelheim’s Nicolas Dumoulin outlines Denmark’s relevance to the German family-owned company, including the strong uptake of its…

Sam Volchenboum – Associate Professor of Pediatrics, Dean…

Dr Sam Volchenboum outlines the progress that has been made in the paediatric oncology field in recent years and his hopes for its future. Dr…

The COVID-19 Pandemic in Japan: Treatments, Vaccines &…

Writing in the August edition of DIA’s Global Forum, Kotone Matsuyama of the Nippon Medical School gives a run-through of Japan's response to the…

Health Technology Assessment in the EU: Back and Forth in Giant…

Writing in the August edition of DIA's Global Forum, Sanofi R&D's Thomas Kühler outlines the bumpy journey towards the full adoption of Health…

Pharma Faces: Dimitri Livadas, Lilly Saudi Arabia

Having commenced his journey with American giant Lilly in 2008, and after almost eight years working in the company’s Japan organization, mostly on…

Liquid Biopsies & The Future of Cancer Diagnostics

In 2020, the FDA granted its first approval to a comprehensive liquid biopsy, potentially representing a paradigm shift towards using liquid biopsies…

Eric Schulze – CEO, Lifetrack Medical Systems

Lifetrack Medical Systems' Dr Eric Schulze explores the origins of his company, how its software platform has the potential to revolutionise radiology…